Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1982 1
1983 1
1984 1
1985 1
1987 2
1988 2
1989 1
1992 1
1993 2
1994 1
1995 6
1996 4
1997 2
1998 6
1999 5
2000 3
2001 7
2002 5
2003 8
2004 9
2005 8
2006 7
2007 9
2008 16
2009 26
2010 28
2011 28
2012 28
2013 24
2014 17
2015 22
2016 26
2017 24
2018 28
2019 25
2020 28
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

367 results
Results by year
Filters applied: . Clear all
Page 1
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, Woods K, Payne AB, Peacock G, Schieve LA. Panepinto JA, et al. Emerg Infect Dis. 2020 Oct;26(10):2473-2476. doi: 10.3201/eid2610.202792. Epub 2020 Jul 8. Emerg Infect Dis. 2020. PMID: 32639228 Free PMC article.
Sickle cell disease (SCD) disproportionately affects Black or African American persons in the United States and can cause multisystem organ damage and reduced lifespan. Among 178 persons with SCD in the United States who were reported to
Sickle cell disease (SCD) disproportionately affects Black or African American persons in the United States and
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N, Kudirka AA, Askar S, Almadhoun K, Kuriakose P, Fadel R, Dabak V. Balanchivadze N, et al. Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28. Hemoglobin. 2020. PMID: 32722950
This retrospective analysis included 24 patients with confirmed COVID-19 and sickle cell disease or trait who were seen at the Henry Ford Hospital, Detroit, MI, USA, between March 1 and April 15 2020. Of the 24 patients, 18 (75.0%) had heterozygous sickle
This retrospective analysis included 24 patients with confirmed COVID-19 and sickle cell disease or trait who were seen at the …
The cost of health care for children and adults with sickle cell disease.
Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. Kauf TL, et al. Am J Hematol. 2009 Jun;84(6):323-7. doi: 10.1002/ajh.21408. Am J Hematol. 2009. PMID: 19358302 Free article.
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. ...
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with …
Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.
Chen Y, White RS, Tangel V, Noori SA, Gaber-Baylis LK, Mehta ND, Pryor KO. Chen Y, et al. J Comp Eff Res. 2019 Apr;8(6):403-422. doi: 10.2217/cer-2018-0098. Epub 2019 Mar 20. J Comp Eff Res. 2019. PMID: 30892071
AIM: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease undergoing total hip and knee arthroplasty (THA and TKA). ...Logistic regression models were used for analysis. RESULTS: Compared with non- …
AIM: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease un …
Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
Peterson EE, Salemi JL, Dongarwar D, Salihu HM. Peterson EE, et al. Eur J Pediatr. 2020 Nov;179(11):1701-1710. doi: 10.1007/s00431-020-03656-x. Epub 2020 May 12. Eur J Pediatr. 2020. PMID: 32394268
The objective of this study was to analyze acute care utilization of sickle cell disease (SCD) and sickle cell trait (SCT) in children and identify trends in emergency department (ED) visits and inpatient admissions over a 10-year period. ...What is Kn …
The objective of this study was to analyze acute care utilization of sickle cell disease (SCD) and sickle cell t …
Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis.
Kumar V, Chaudhary N, Achebe MM. Kumar V, et al. Sci Rep. 2020 Feb 7;10(1):2082. doi: 10.1038/s41598-020-58934-3. Sci Rep. 2020. PMID: 32034210 Free PMC article.
The 30-day readmission rate after hospitalization for a sickle cell crisis (SCC) is extremely high. Accurate information on readmission diagnoses, total readmission costs and factors associated with readmission is required to effectively plan resource allocation and …
The 30-day readmission rate after hospitalization for a sickle cell crisis (SCC) is extremely high. Accurate information on re …
The Impact of Sickle Cell Anemia and Mental Health Diagnoses on Healthcare Use and Preventive Care among Children Enrolled in Medicaid, 2005-2012.
Gondhi JP, Dombkowski KJ, Scott EL, Reeves SL. Gondhi JP, et al. J Pediatr. 2020 Sep;224:79-86.e2. doi: 10.1016/j.jpeds.2020.05.027. Epub 2020 May 22. J Pediatr. 2020. PMID: 32446724
OBJECTIVE: To examine mental health diagnoses, healthcare use, and receipt of age-appropriate preventive care, including antibiotic prophylaxis, hydroxyurea therapy, and transcranial Doppler screenings, among children with sickle cell anemia (SCA). STUDY DESIGN: Chi …
OBJECTIVE: To examine mental health diagnoses, healthcare use, and receipt of age-appropriate preventive care, including antibiotic prophyla …
Sickle cell disease complications: Prevalence and resource utilization.
Shah N, Bhor M, Xie L, Paulose J, Yuce H. Shah N, et al. PLoS One. 2019 Jul 5;14(7):e0214355. doi: 10.1371/journal.pone.0214355. eCollection 2019. PLoS One. 2019. PMID: 31276525 Free PMC article.
OBJECTIVES: This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC episodes, and the primary reasons for emergency room (ER) visits and inpatient admissions for sickle cell disease (SCD) patients. …
OBJECTIVES: This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC epi …
Inpatient mortality and postpartum readmission rates in sickle cell disease pregnancies: a multistate analysis, 2007-2014.
Bae E, Tangel V, Liu N, Abramovitz SE, White RS. Bae E, et al. J Matern Fetal Neonatal Med. 2021 Sep;34(17):2783-2792. doi: 10.1080/14767058.2019.1671333. Epub 2019 Oct 6. J Matern Fetal Neonatal Med. 2021. PMID: 31588827
OBJECTIVE: We compared post-partum outcomes between sickle cell disease (SCD) and non-sickle cell populations. METHODS: We conducted a retrospective analysis of discharge data for 6,911,916 inpatient deliveries in the states of California, Flori …
OBJECTIVE: We compared post-partum outcomes between sickle cell disease (SCD) and non-sickle cell populations. M …
Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, Treadwell MJ. Kayle M, et al. Pediatr Blood Cancer. 2020 May;67(5):e28152. doi: 10.1002/pbc.28152. Epub 2020 Mar 8. Pediatr Blood Cancer. 2020. PMID: 32147964 Free PMC article.
PURPOSE: Sickle cell disease (SCD) is associated with high acute healthcare utilization. ...METHODS: Individuals with SCD (65 years and enrolled in Medicaid for 6 total calendar months any year between 2011 and 2016) were identified in a multisource database maintai …
PURPOSE: Sickle cell disease (SCD) is associated with high acute healthcare utilization. ...METHODS: Individuals with SCD (65 …
367 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page